KRTL Biotech is a research and development company who are working with CBD and psilocybin in the US and Korea.
KRTL Biotech
Through KRTL Asia, the KRTL team in the US are working with their partners in Korea in order to advance our understanding surrounding psilocybin and develop psilocybin as medicine. KRTL have obtained approval from the Ministry of Food and Drug Safety (MFDS) in Korea in order to carry out their psilocybin research.
The company are looking to develop psilocybin therapy for the treatment of disorders including pain, Autism, PTSD, ADHD, depression and addiction, amongst order psychological disorders.
Activities
B2B
B2C
Pharmaceutical
Biotech
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates